Yuan et al. found that the survival rate of HCC patients with high expression of SMAD4 and TGF-β was significantly lower than that of patients with low expression by analysing The Cancer Genome Atlas (TCGA) database86. Here, SMAD4 is linked to hepatocellular carcinoma.